Invention Grant
- Patent Title: Intermediates for macrocyclic compounds
-
Application No.: US14873056Application Date: 2015-10-01
-
Publication No.: US10040751B2Publication Date: 2018-08-07
- Inventor: Eric Marsault , Kamel Benakli , Hamid Hoveyda , Mark L. Peterson , Sylvie Beaubien , Luc Ouellet , Carl St-Louis , Sophie Beauchemin
- Applicant: OCERA THERAPEUTICS, INC.
- Applicant Address: US CA Palo Alto
- Assignee: Ocera Therapeutics, Inc.
- Current Assignee: Ocera Therapeutics, Inc.
- Current Assignee Address: US CA Palo Alto
- Agency: Ward and Smith, P.A.
- Priority: WOPCT/CA2004/000913 20040618
- Main IPC: A01N29/12
- IPC: A01N29/12 ; A61K31/03 ; C07C213/08 ; A61K38/12 ; A61K38/22 ; C07D273/00 ; C07D413/06 ; C07D498/04 ; C07K5/087 ; C07K5/097 ; C07K5/08 ; C07C41/18 ; C07C67/343
Abstract:
The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: wherein R1, R2, R3, R4, R5, R6, n1, m, p Z1, Z2, and Z3 are as described in the specification. The invention also relates to compounds of formula (I) which are antagonists of the motilin receptor and are useful in the treatment of disorders associated with this receptor and with or with motility dysfunction.
Public/Granted literature
- US20160221927A1 INTERMEDIATES FOR MACROCYCLIC COMPOUNDS Public/Granted day:2016-08-04
Information query
